In recognition of Head and Neck Cancer Awareness Month, Oncofocus has released a concise and easy-to-read infographic that outlines the current approved therapies and noteworthy emerging therapies. Stay informed and help spread HNC awareness with this publicly accessible infographic.

Since March is Multiple Myeloma Awareness Month, we at Oncofocus have created an informative infographic highlighting the current treatment options and emerging therapies for Multiple Myeloma.

Biliary tract cancers, encompassing bile duct and gallbladder malignancies, originate from the bile duct epithelium. Cholangiocarcinoma, or bile duct cancer, affects approximately 8,000 individuals annually in the United States, while gallbladder cancer is even less common, with an incidence rate of about 2 per 100,000 people. These cancers are frequently diagnosed at advanced stages, leading to poor prognoses. In the US and EU, treatment options remain scarce, although recen

Focus: Multiple Myeloma Indication Multiple Myeloma is the second most common hematologic malignancy and is largely considered incurable....

Focus - Melanoma Indication Malignant melanoma is a complex, multifactorial disease, which is responsible for up to 75% of skin...

Focus - Small Cell Lung Cancer Indication SCLC is an unforgiving, highly aggressive variant of lung cancer. It accounts for approximately...